Anupama Mehta, MD Associate Surgeon, Division of Trauma, Burn, Surgical and Critical Care Medical Director, Burn Center, Brigham and Women’s Hospital
Dr. Mehta graduated with honors from Rutgers College and obtained her medical degree from the University of Vermont. She completed a general surgery residency at Loyola University Medical Center and a burns and critical care fellowship at the University of Southern California, Los Angeles. Dr. Mehta is board certified in general surgery and surgical critical care. She is also a member of the American Burn Association (ABA) and the American College of Surgeons (ACS).
Dr. Mehta’s clinical interests include burn surgery and reconstruction, wound healing, scar tissue management and burn critical care. She also treats pediatric burns and patients with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Additionally, she has interests in faculty development and resident wellness initiatives.
Dr. Mehta succeeds Stephanie Nitzschke, MD, MS, who has served as medical director of the Burn Center since 2017.
Eric Sheu, MD, PhD, has been awarded a $3.3M NIH R01 grant for the study, “A microbiome-dependent bile acid metabolite improves type 2 diabetes.”
Dr. Sheu’s group has identified a bile acid metabolite, CA7S, that is generated by bariatric surgery and has anti-diabetic properties. This study’s goals are to evaluate the CA7S metabolite as a novel therapy for type 2 diabetes; uncover how CA7S production is regulated by the gut microbiome; and determine the contribution of CA7S to type 2 diabetes remission, following bariatric surgery. The study is funded by the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), whose mission is to conduct and support medical research and research training and to disseminate science-based information on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases, to improve people’s health and quality of life.
Eric Sheu, MD, PhD Associate Surgeon, Division of General and Gastrointestinal Surgery, Brigham and Women’s Hospital Associate Program Director, Advanced Minimally Invasive Surgery Fellowship, Brigham and Women’s Hospital Assistant Professor of Surgery, Harvard Medical School
Dr. Sheu is a bariatric and minimally invasive surgeon at Brigham and Women’s Hospital, an assistant professor of surgery at Harvard Medical School and associate program director of the advanced minimally invasive surgery fellowship at the Brigham. Dr. Sheu graduated from Harvard College, obtained his doctorate in immunology as a Marshall Scholar at Oxford University and completed medical school at Harvard Medical School. He trained in general surgery at the Brigham, followed by a fellowship in advanced laparoscopy and bariatric surgery at Massachusetts General Hospital.
Dr. Sheu’s clinical practice focuses on bariatric, foregut and hernia surgery. He directs an NIH R01-funded laboratory that investigates how changes in immunology and metabolism triggered by bariatric surgery lead to resolution of type 2 diabetes. His research has been supported by numerous societies and philanthropic institutions, including the American Surgical Association (ASA), the Blavatnik Biomedical Accelerator, the Quadrangle Fund for Advancing and Seeding Translational Research (Q-FASTR) and Harvard Catalyst.
